From the Festival Forum to The Agency Business 3.0, our popular weekly series of livestreamed panels are available to watch on demand
IQ Focus was a weekly series of livestreamed panels that debuted in May 2020, inviting heavyweights from the international live music business to discuss issues ranging from the trials and tribulations of a pandemic to the systemic racism brought to light by Blackout Tuesday, and everything in between.
But it hasn’t all been doom and gloom. The Innovation Session heard panellists discuss the flurry of innovation, fledgling business models, and new ideas that have come out of the coronavirus crisis. Staying Safe & Sane During Covid presented expert opinions on how to protect the mental health and wellbeing of music professionals and artists. What all these sessions have had in common is a sense of optimism, opportunity and determination, as our industry forges ahead into the unknown.
The featured session above – The Lost Causes – aired in August 2020, and saw specialists discuss the impact of Covid on key causes and topics across the business.
As parts of the live business begin to restart, IQ Focus looks at the technology available to event organisers and venue operators to ensure safe and profitable reopening
'Laura Marling – A Streaming Success' gathered together the team behind the singer’s Union Chapel concerts to discuss the ins and out of the ticketed live stream game
Representatives from Mad Cool, ARTmania, Isle of Wight and Melt festivals came together in IQ’s second festival panel, to take stock of where Covid-19 has left the sector
The Agency Business 3.0 looked at the push for greater inclusion in live music, as well as the role of the agent amid the rise of livestreaming and virtual shows
Grassroot venue champions from the UK, Europe and the US came together for the fifth IQ Focus session to discuss the future of this important part of the industry
The Recovery Sessions is a series of conversations – free to subscribers – on the latest developments around the COVID-19 pandemic & the roadmap to reopening
